- World rank, all time
- #23,179 of 42,892
- Rank in Israel
- #99 of 156
- Research works
- 144 ▼ 5% vs 2013–17
- Citations
- 6.5k 45.2 per fractional work
- Top-10% rate
- 16.7% record average 16.5%
- Open access
- 40% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 9.8×. Every wedge is a field page.
- Immunology and Microbiology 9.8×
- Nursing 6.1×
- Decision Sciences 3.5×
- Business, Management and Accounting 2.5×
- Medicine 2.0×
- Agricultural and Biological Sciences 1.9×
- Neuroscience 1.9×
- Biochemistry, Genetics and Molecular Biology 1.6×
- Health Professions 0.8×
- Mathematics 0.7×
- Psychology 0.6×
- Social Sciences 0.5×
- Computer Science 0.4×
- Earth and Planetary Sciences 0.2×
- Economics, Econometrics and Finance 0.2×
- Engineering 0.1×
- Environmental Science 0.1×
Who are the top researchers at Compugen (Israel)?
Ranked on the composite score, Eran Ophir, Pierre Ferré and Gady Cojocaru lead among researchers whose main affiliation is Compugen (Israel).
- 1 Eran Ophir Israel · #1,284,357 worldwide 18 citations · 16 works
- 2 Pierre Ferré Israel · #1,565,450 worldwide 8 citations · 20 works
- 3 Gady Cojocaru Israel · #1,606,288 worldwide 2 citations · 19 works
Which keywords describe research at Compugen (Israel)?
By fractional works in all years, weighted toward what it does more of than the world: Tumor Microenvironment, Ribosome, Translation, Cancer, Innate Immunity, Immune Checkpoint Blockade, PD-1 and PD-L1 and Cancer Immunotherapy.
- Anticancer
- Tumor Antigen
- Prediction
- Mass Spectrometry
- Natural Killer Cells
- Dendritic Cells
- genome annotation
- RNA-Seq
- Molecular Docking
- Quality Assessment
- Alternative Splicing
- Phylogenetic Analysis
- Angiogenesis
- Drug Discovery
- Immunity
- Gene Expression
- Immune Checkpoint Blockade
- Inflammation
- Ribosome
- Tumor Microenvironment
- Cancer
- Machine Learning
- Translation
- Innate Immunity
- PD-1 and PD-L1
- Cancer Immunotherapy
- Antigen Presentation
- Immunotherapy
- Bioinformatics
- Glycosylation
- Data Analysis
- RNA-Binding Proteins
- Gene Regulation
- Cancer Progression
- sequence alignment
- NK Cell Recognition
- Genomic Studies
- Normalization
- Protein
- Vaccine Adjuvants
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cancer8▲ 3.8×18 topics
- Tumor Microenvironment8▲ 15×4 topics
- Machine Learning7▲ 2.3×14 topics
- Ribosome6▲ 43×1 topic
- Translation6▲ 20×1 topic
- Inflammation6▲ 1.75×25 topics
- Innate Immunity5▲ 10×9 topics
- Immune Checkpoint Blockade5▲ 63×1 topic
- PD-1 and PD-L15▲ 63×1 topic
- Gene Expression5▲ 5.4×10 topics
- Cancer Immunotherapy5▲ 23×3 topics
- Immunity4▲ 9.2×3 topics
- Antigen Presentation4▲ 28×2 topics
- Drug Discovery4▲ 6.2×4 topics
- Immunotherapy4▲ 3.8×7 topics
- Angiogenesis3▲ 5.8×9 topics
- Bioinformatics3▲ 20×3 topics
- Phylogenetic Analysis3▲ 6.0×4 topics
- Glycosylation3▲ 10×3 topics
- Alternative Splicing3▲ 34×1 topic
- Data Analysis3▲ 6.5×3 topics
- Quality Assessment3▲ 11×3 topics
- RNA-Binding Proteins3▲ 34×1 topic
- Molecular Docking3▲ 15×2 topics
- Gene Regulation3▲ 13×3 topics
- RNA-Seq3▲ 21×2 topics
- Cancer Progression3▲ 8.3×4 topics
- genome annotation3▲ 26×1 topic
- sequence alignment3▲ 26×1 topic
- Dendritic Cells3▲ 16×2 topics
- NK Cell Recognition3▲ 18×1 topic
- Natural Killer Cells3▲ 18×1 topic
- Genomic Studies2▲ 20×2 topics
- Mass Spectrometry2▲ 8.3×3 topics
- Normalization2▲ 24×2 topics
- Prediction2▲ 17×2 topics
- Protein2▲ 11×2 topics
- Tumor Antigen2▲ 21×1 topic
- Vaccine Adjuvants2▲ 21×1 topic
- Anticancer2▲ 8.0×5 topics
Which research topics does Compugen (Israel) publish most on?
By volume in 2022–2025: Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Soil Management and Crop Yield and Immune Cell Function and Interaction.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Immunotherapy and Biomarkers Oncology 2 works
- 2 CAR-T cell therapy research Oncology 1 works
- 3 Soil Management and Crop Yield Soil Science 1 works
- 4 Immune Cell Function and Interaction Immunology 1 works
- 5 Immunotherapy and Immune Responses Immunology 1 works
- 6 Mesenchymal stem cell research Genetics 0 works
- 7 Healthcare Systems and Public Health Epidemiology 0 works
- 8 AI and HR Technologies Organizational Behavior and Human Resource Management 0 works
- 9 Renal cell carcinoma treatment Pulmonary and Respiratory Medicine 0 works
- 10 Financial Distress and Bankruptcy Prediction Accounting 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Compugen (Israel)'s research output changed?
Output in 2018–2022 was 5% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Tel Aviv
- Tel Aviv University
- Tel Aviv Sourasky Medical Center
- Assaf Harofeh Medical Center
- General Electric (Israel)
- Israel Atomic Energy Commission
- Clalit Health Services
- Academic College of Tel Aviv-Yafo
- Meta (Israel)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.